Prof. John Smyth, Assistant Principal for Cancer Research Development at University of Edinburgh, discusses the issue of the cost of licensing trials with managing editor Professor Gordon McVie, at EC...
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - Young people with cancer
Dr Jeremy Whelan discusses cancer care for adolescents, specifically looking at the issues faced by young people and how their needs can be addressed.
Author: ecancertv
Added: 04/23/2010
ECCO 15 - ESMO 34 Guidelines for safer handling of cytotoxics
Dr Klaus Meier, President of the European Society of Oncology Pharmacy, discusses the society's latest work of preparing centralised guidelines for the preperation of cytotoxic treatments with managin...
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - Circulating tumour cells
Anieta Sieuwerts of the Erasmus University in Rotterdam discusses the research presented on circulating tumour cells at ECCO 15 - ESMO 34 in Berlin 2009.
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - Early detection of cancer
Prof. Ron Laskey, University of Cambridge, talks about research into identifying malignant and pre-malignant cells in body fluids for the early detection of cancer.
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - PET in the treatment of Hodgkin's Lymphoma
Dr Lena Specht discusses the use of PET imaging in the treatment of Hodgkin's Lymphoma.
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - Triple negative breast cancer
Features of triple negative breast cancer and various cancers within the triple negative grouping. PARP inhibitors. Grouping tumours by similarity to BRCA 1- 'BRCAness'. Multidisciplinary teams.
D...
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - Prioritisation in cancer research
Prof Sullivan discusses the current European and global effort to prioritise different areas of cancer research.
Prof Richard Sullivan of King's College, London, speaking to Prof Gordon McVie, Man...
Author: ecancertv
Added: 04/23/2010
ECCO 15 ESMO 34 - The problems of getting new molecules to the clinic
Newer mouse models needed for testing drugs. Need to reduce failure rate of new drugs. Academia's role in drug development. Epigenetic targets.
Prof Mariano Barbacid of the Spanish National Cancer ...
Author: ecancertv
Added: 04/23/2010
Dr. Umberto Veronesi - Six Weeks of Radiation Therapy May Be Unnecessary for Many Breast Cancer Patients
Renowned surgeon Dr. Umberto Veronesi, founder of the European Institute of Oncology, shared for the first time the results of a long-awaited, eight-year randomized trial comparing his breast cancer p...
Author: medized
Added: 04/22/2010
ECCO 15 ESMO 34 Current situation with aromatase inhibitors
Prof Charles Coombes of the Imperial College School of Medicine, London, UK, speaking at ECCO 15 - ESMO 34, Sept 2009, Berlin:
Current situation with aromatase inhibitors. Increase in disease free...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - European Association for Cancer Research
Prof Anne-Lise Borresen-Dale - President of the European Association for Cancer Research, speaking at ECCO 15 - ESMO 34, Sept 2009, Berlin, about her work leading basic science against cancer.
Author: ecancertv
Added: 04/22/2010
The latest advances in radiation oncology
What's driving radiation oncologists at the moment? Changing practice to take into account genetic information on resistance to radiation. Combining genetic information with imaging. Normal tissue rea...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Radioimmunotherapy with Y-90-ibritumomab tiuxetan in extranodal marginal zone lymphoma
Dr Vanazzi discusses the trial investigating radioimmunotherapy with Y-90-ibritumomab tiuxetan in extranodal marginal zone lymphoma, a disease that currently has no standard treatment after primary th...
Author: ecancertv
Added: 04/22/2010
ECCO 15 - ESMO 34 Conference
Prof José Baselga, President of ESMO, discusses the ECCO 15 - ESMO 34 Conference in Berlin, September 2009.
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Cryopreservation of ovarian tissue
Prof Jacques Donnez of the Catholic University of Louvain, Brussels, Belgium, speaking at the ECCO 15 - ESMO 34 Conference about preserving fertility in young patients receiving treatment for ovarian ...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes
Dr Marjut Leidenius from the Breast Surgery Unit, Helsinki University Central Hospital discusses her work with the prognostic value of isolated tumour cells in breast cancer sentinel nodes.
Speaki...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - European action against rare cancers
Dr Paolo Casali an Executive Commitee Member of the European Society for Medical Oncology discusses ESMO's new initiative to colate action against rare cancers across Europe
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Epidemiology of colorectal cancer and surgical treatment
Dr Gabriela Moeslein of St Josef's Hospital, Bochum-Linden, Germany, speaking at ECCO 15 - ESMO 34 in Berlin, 2009.
Familial risk of colorectal cancer, CAP study on aspirin for colorectal cancer p...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Hyper-reactions to radiotherapy
Dirk De Ruysscher, from the University Hospital Maastricht, Netherlands, discusses his work studying the genetics of patients and predicting reaction to radiotherapy, in order to improve efficiency.
...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Increasing prostate cancer awareness
Tom Hudson, Chair of Europa Uomo, discusses Europa Uomo's aim to increase awareness of prostate cancer and the importance of presenting symptoms.
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - European Action Against Rare Cancers
Kathy Oliver, Director of the International Brain Tumour Alliance, discusses the launch of the European Action Against Rare Cancers initiative, also her 'Walk around the world for brain tumours' fundr...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - The patient perspective
Jan Geissler, Director of the European Cancer Patient Coalition, discusses the ECCO 15 - ESMO 34 meeting, from a patients perspective, Berlin 2009.
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Importance of exchanging scientific information
Professor Jean-Yves Blay talks about the importance of the ECCO-ESMO meetings for bringing together scientists, researchers, oncologists and patients to exchange scientific information, which then lea...
Author: ecancertv
Added: 04/22/2010
ECCO-ESMO Patient advocacy symposium conclusions
Sandra Craine from the Chronic Myeloid Leukaemia Support Group, UK, discusses the conclusions of the patient advocacy symposium at ECCO 15- ESMO 34, Berlin , 2009.
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Breast cancer screening in older women
Professor Silvio Monfardini discusses the issue of screening ages for mammography, and the different standards across Europe. He suggests reasons why the screening age should be increased to over 70. ...
Author: ecancertv
Added: 04/22/2010
ECCO 15 ESMO 34 - Targeted agents in the treatment of advanced NSCLC
Targeted agents in the treatment of advanced NSCLC. New data on Zactima. Zactima in combination with standard chemotherapy. Immunotherapy and the MAGE-A3 vaccine.
Prof Johan Vansteenkiste of the L...
Author: ecancertv
Added: 04/22/2010
Relapsed and Refractory Lymphoma: What It's Like When the Unexpected Happens
Topics Include: Discovering the relapse. How is a relapse/recurrance different than initial diagnosis? How do I deal? Sadness, anger and unexpected anxiety
Author: lymphomaresearch
Added: 04/21/2010
What is a Clinical Trial?
Topics covered are: What are the Phases of a Clinical Trial? Participating in Clinical Trials; What do I need to know? Will my insurance cover the costs? Can I say "no" or drop out? Will I r...
Author: lymphomaresearch
Added: 04/21/2010
Relapsed or Refractory Aggressive Lymphomas Medical Aspects (Part 1)
Topics include: Difference between Hodgkin and Non-Hodgkin Lymphoma, what is relapsed or refractory disease and when can it happen? What are the treatment options for relapsed or refractory lymphoma? ...
Author: lymphomaresearch
Added: 04/21/2010
Lymphoma Research Foundation -Cutaneous Lymphoma Basics and Treatment Options
Having a cutaneous lymphoma in your 20s or 30s can create lifestyle and personal challenges that people with other types of cancer do not experience. These unique aspects of living with cutaneous lymp...
Author: lymphomaresearch
Added: 04/21/2010
Lymphoma Research Foundation Watchful Waiting
Watchful waiting is a treatment option commonly used for indolent lymphomas. It is a time of close follow-up and monitoring of ones disease, but a time when no active treatment (e.g., chemotherapy) is...
Author: lymphomaresearch
Added: 04/21/2010
Lymphoma Research Foundation Managing Fear and Uncertainty
Because indolent lymphomas often require a cycle of starting and stopping treatment, fear and uncertainty about when the lymphoma may recur and require treatment is common. This webcast addresses thes...
Author: lymphomaresearch
Added: 04/21/2010
Lymphoma Research Foundation Talking to Friends & Family
Issues related to friends and families are unique when you or someone you know is diagnosed with lymphoma in their 20s and 30s. Insight from other young adults and patient support professionals in thi...
Author: lymphomaresearch
Added: 04/21/2010
Milano 27-02-10 3° Convegno Nazionale AIG: Chirurgia della Malattia in Progressione
Dott. Vittorio Quagliuolo, Responsabile Sezione di Chirurgia dei Sarcomi
IRCCS Istituto Clinico Humanitas, Rozzano, Milano
Author: gistonline
Added: 04/21/2010
ECCO 15 ESMO 34 - The role of EONS, patient interaction and oncology nursing variations by country
Sarah Faithful - President of the European Oncology Nursing Society - Role of EONS at the conference, interactions between healthcare professionals and patients, and variation in oncology nursing by c...
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34 - Panel Discussion
A panel discussions at the ECCO 15 - ESMO 34 Cancer Conference in Berlin.
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34 - A new era of melanoma treatment
Prof Alexander Eggermont, President of the European CanCer Organisation, talks to Editor Gordon McVie about a new era of melanoma treatment, immunomodulation, combination immunotherapy, ipilimumab's u...
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34 - ANTI-CTLA-4: A new immunological approach
Dr Jeff Weber - Moffitt Cancer Center, Tampa, Florida, USA
Current challenges in the treatment of advanced melanoma satellite symposium: new approaches in advanced melanoma. Official joint ECCO 15 ...
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34: The Second Opinion Panel - a programme allowing Danish patients to receive specialist treatment abroad
Prof Heine Hansen talks about a pilot study called the Second Opinion Panel that has been set up with support from the Danish Health Minister. This study allows any cancer patients looking for a secon...
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34: Compounds to improve disease control in advanced breast cancer
Expert interview, conducted by Prof Gordon McVie, with Dr Peyman Hadji - Head of the Department of Endocrinology, Osteoporosis and Reproductive Medicine at Philipps-University of Marburg, Germany
O...
Author: ecancertv
Added: 04/21/2010
ECCO 15 - ESMO 34 News 20-21 September, 2009
Prof Gordon McVie - ecancer Managing Editor, gives his round up of the first two days of ECCO 15 - ESMO 34 Cancer Conference in Berlin.
Author: ecancertv
Added: 04/21/2010
ECCO 15 - ESMO 34 News 23rd September 2009
Prof Gordon McVie - ecancer Managing Editor, gives his final round up of the ECCO 15 - ESMO 34 Cancer Conference in Berlin.
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34 - Round up for second day of the ECCO 15 - ESMO 34 Cancer Conference in Berlin
Prof Gordon McVie - ecancer Managing Editor, gives his round up of the 2nd day of ECCO 15 - ESMO 34 Cancer Conference in Berlin.
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34 - International clinical trial establishes aspirin protects against colorectal cancer
Prof John Burn of the Institute of Human Genetics, Newcastle University, UK, talks to ecancer editor Prof Gordon McVie about the results and possibilities opened by his trial which investigated the ef...
Author: ecancertv
Added: 04/21/2010
Collaboration between Anals of Oncology, ESMO and JSMO
Prof Jan B Vermorken, Editor-in-chief of Anals of Oncology discusses the role the journal plays and speaks of planned future developments such as free online access to papers.
Prof Vermorken is jo...
Author: ecancertv
Added: 04/21/2010
ECCO and ESMO join forces
Alexander M.M. Eggermont president of ECCO, and José Baselga, president of ESMO, discuss the new initiative between their organisations
Author: ecancertv
Added: 04/21/2010
ECCO 15 ESMO 34: Novel hormonal agents in early breast cancer
Expert interview conducted by Prof Gordon McVie with Julie Doughty, MD - Consultant Breast and Endocrine Surgeon, Western Infirmary, Glasgow, Scotland.
Women diagnosed with breast cancer face the r...
Author: ecancertv
Added: 04/21/2010
SABCS 2009
Interview at SABCS
Author: cancerconnect
Added: 04/20/2010
ECCO 15 - ESMO 34: New targeted drugs for metastatic renal cell carcinoma
Expert interview conducted by Prof Gordon McVie with Dr Joaquim Bellmunt MD PhD - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain
Metastatic renal cell carcinoma (RCC) has p...
Author: ecancertv
Added: 04/20/2010
ECCO 15 - ESMO 34: Current Challenges in the Treatment of Advanced Melanoma
Satellite Symposium: New Approaches in Advanced Melanoma. Official joint ECCO 15 and 34th ESMO Multidisciplinary Congress Sponsored Satellite Symposium Held on 20th September 2009
Author: ecancertv
Added: 04/20/2010
ECCO 15 - ESMO 34: New insights in staging tools, surgical, and medical management of stage II-III melanoma
Prof Alexander M. M. Eggermont - Erasmus University, Rotterdam, the Netherlands
Satellite Symposium: New Approaches in Advanced Melanoma Official joint ECCO 15 and 34th ESMO Multidisciplinary Congr...
Author: ecancertv
Added: 04/20/2010
Milano 27-02-10 3° Convegno Nazionale AIG: Livello di Imatinib nel plasma
Dott. Daniele Morelli, Responsabile Medicina di Laboratorio
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Author: gistonline
Added: 04/20/2010
SABCS 2009: Could Targeting Breast Cancer Stem Cells Be the Answer?
Dr. Jenny Chang of Baylor College of Medicine discusses stem cell research in breast cancer.
Author: cancerconnect
Added: 04/20/2010
What is Colorectal Cancer?
Dr. Allyson Ocean discusses colorectal cancer.
Author: cancerconnect
Added: 04/19/2010
Colorectal Cancer: Treatment and Clinical Trials
Dr. Allyson Ocean discusses the treatment of colorectal cancer.
Author: cancerconnect
Added: 04/19/2010
Colorectal Cancer: Testing and Staging
Dr. Allyson Ocean discusses the diagnosis and staging of colorectal cancer.
Author: cancerconnect
Added: 04/19/2010
Highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March
In anticipation of the many highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March, key experts highlight the uniqueness of full patient integration at EBCC meetings and under...
Author: ecancertv
Added: 04/19/2010
Roundup of the 7th European Breast Cancer Conference, Barcelona
Although we can be optimistic thanks to the great advances that have been made in the field, there are still unacceptable levels of variation, with high cancer rates found in certain countries and soc...
Author: ecancertv
Added: 04/19/2010
EBCC 6: Conference highlights from Europa Donna
Susan Knox, Executive Director of Europa Donna, a Europe-wide coalition of affiliated groups of women that facilitates the exchange and spread of pertinent information concerning breast cancer through...
Author: ecancertv
Added: 04/19/2010
EBCC 6: Epigenetics in cancer care
Prof. Romano Danesi, Dept. of Internal Medicine, University of Pisa.
Prof Danesi discusses the rose of epigenetics in cancer care, the ways of predicting the response or toxicity of treatments such...
Author: ecancertv
Added: 04/19/2010
EBCC 6: Variations in treatments with aromatase Inhibitors
Professor Per Lønning, Medical Oncologist at the University of Bergen, discusses the differences between the aromatase inhibitors letrozole, anastrozole, and exemustane. Prof. Lonning also highlights ...
Author: ecancertv
Added: 04/19/2010
EBCC 6: Improving breast cancer care using biomarker tests.
Prof. Mitch Dowsett, Head of Department of Biochemistry at the Institute of Cancer Research, Royal Marsden, UK.
Prof. Dowsett discusses biomarker tests; what purpose they serve within cancer treatm...
Author: ecancertv
Added: 04/19/2010
EBCC 6: NHS spending on cancer
Prof. Mike Richards National Cancer Director, Department of Health, UK
Prof. Richards speaks about the amount of monet invested into cancer treatments in the UK and what are the priorities within t...
Author: ecancertv
Added: 04/19/2010
Milano 27-02-10 3° Convegno Nazionale AIG: La gestione della terapia e degli effetti collaterali
Dott. Alessandro Comandone, Responsabile SC Oncologia Medica
Presidio Sanitario Gradenigo, Torino
Author: gistonline
Added: 04/19/2010
EBCC6: Safety and efficacy of chemotherapy before surgery
Professor Michael Untch, University of Munich and Breast Cancer Centre.
Prof. Untch discusses his study into combining trastuzumab with neoadjuvant chemotherapy before surgery and surprising new da...
Author: ecancertv
Added: 04/16/2010
Prof Julie Gralow discusses her main points of interest from EBCC 6
Prof. Julie Gralow, Medical Oncology at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center.
Prof. Gralow speaks about her highlights from the conference. A l...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Conference highlights and future of breast cancer care
Prof. Emiel Rutgers, Netherlands Cancer Institute and EBCC 6 Conference Chair.
Prof Rutgers discusses conference highlights and future of breast cancer care including: the importance of frozen tumo...
Author: ecancertv
Added: 04/16/2010
EBCC 6: The importance of epigenetics in the future direction or breast cancer treatment
Prof. Anne-Lise Børresen-Dale, President of European Association of Cancer Research (EACR).
Prof. Børresen-Dale discusses the importance of a multi discipline approach to cancer treatment. It is st...
Author: ecancertv
Added: 04/16/2010
Breast cancer trials held at the European Institute of Oncology.
Prof. Aaron Goldhirsch, Director of The Department of Medicine, IEO, Milan
Prof. Goldhirsch speaking about the future of breast cancer trials. In the future trials may be held on a smaller scale an...
Author: ecancertv
Added: 04/16/2010
EBCC 6: New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.
Professor Gunter von Minckwitz, Chairman of the German Breast Group.
Prof. von Minckwitz discusses a trial investigating the use of capecitabine as a chemotherapeutic drug to treat breast cancer. T...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Acupuncture for Tamoxifen-Induced Hot Flushes
Hot flushes caused by Taoxifen can be damaging to patients quality of life, and frequently prevent patients from getting a good nights sleep.
Mrs Jill Hervik, Physiotherapist and Acupuncturist at ...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Acupuncture as treatment for hot flushes in patients using anti-oestrogen medication.
Mrs Jill Hervik, Physiotherapist and Acupuncturist, Vestfold Central Hospital, Norway.
Mrs Hervik speaks about a study which has has successfully reduced the hot flushes commonly caused by anti-oe...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Giovanna Gatti outlines the aims of the Fondazione Umberto Veronesi (FUV)
Dr Giovanna Gatti explains the aims of FUV, these are primarily the diffussion of science to doctors, scientists and the general public, and to help the progress of science and peoples understanding o...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Roundup
Overview of the 6th European Breast Cancer Conference in Berlin, 15-19 April 2008, the most successful European Breast Cancer Conference yet.
Author: ecancertv
Added: 04/16/2010
ECCO and ESMO join forces
Michel Ballieu, CEO of ECCO, and Åge Schultz, Executive Director of ESMO, discuss the new collaboration between ECCO and ESMO and how this will help the progress of European oncology.
Author: ecancertv
Added: 04/16/2010
EBCC6: Chemotherapy for pregnant breast cancer patients
Dr Sibylle Loibl, German Breast Group.
Dr Sibylle Loibl discusses her research on chemotherapy for pregnant breast cancer patients and gives advice to doctors based on the findings.
Author: ecancertv
Added: 04/16/2010
EBCC6: Pregnant patients lose out in breast cancer treatment.
Dr. Sibylle Loibl discusses data that shows pregnant breast cancer patients do not receive the correct breast cancer treatment. Treating pregnant patients with chemotherapy did not compromise birth we...
Author: ecancertv
Added: 04/16/2010
EBCC6: Is an annual mammogram better than a three-yearly one.
Professor Roger Blamey discusses a trial conducted to find out if an annual mammogram better than a three-yearly one. The trial also aimed to decide if women should be screened up to the age of 75.
Author: ecancertv
Added: 04/16/2010
EBCC6: Safety and efficacy of chemotherapy before surgery
Professor Michael Untch, University of Munich and Breast Cancer Centre.
Prof. Untch discusses his study into combining trastuzumab with neoadjuvant chemotherapy before surgery and talks about using...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Upper age limits for effective breast mammograms.
Dr. Jacques Fracheboud discusses his research investigating upper age limits for effective breast mammograms.
The study concludes that mamagrams are effective up the the age of 75, and the extensi...
Author: ecancertv
Added: 04/16/2010
EBCC6: Obese women disadvantaged in both treatment and diagnosis.
Dr. Evandro de Azambuja discusses clinical trials that have shown obese women are disadvantaged in both treatment and diagnosis of breast cancer.
Author: ecancertv
Added: 04/16/2010
EBBC6: New strategies needed to deal with breast cancer and obesity.
Dr Elisabetta Rapiti, Geneva Cancer Registry, Switzerland.
Dr Elisabetta Rapiti discusses her findings on breast cancer and obesity and suggests new strategies are needed to deal with the problems,...
Author: ecancertv
Added: 04/16/2010
EBBC6: New strategies needed to deal with breast cancer and obesity.
Dr Elisabetta Rapiti, Geneva Cancer Registry, Switzerland.
Dr Elisabetta Rapiti discusses her findings on breast cancer and obesity and suggests new strategies are needed to deal with the problems,...
Author: ecancertv
Added: 04/16/2010
EBBC6: The benefits of pre-op MRI scans for all breast cancer patients
David Martinez-Cecilia, General Surgery Service, Spain
David Martinez-Cecilia discusses the benefits of pre-op MRI scans for all breast cancer patients
Author: ecancertv
Added: 04/16/2010
EBBC6: The benefits of pre-op MRI scans for all breast cancer patients
David Martinez-Cecilia, General Surgery Service, Spain.
David Martinez-Cecilia discusses the benefits of pre-op MRI scans for all breast cancer patients
Author: ecancertv
Added: 04/16/2010
EBCC 6: Findings on Lapatinib's role in tackling cancer stem cells
Dr. Angel Rodriguez, Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Speaking at the 6th European Breast Cancer Conference in Berlin - explains the research into Lapatinib's ...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Findings on Lapatinib's role in tackling cancer stem cells
Dr. Angel Rodriguez, Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Interviewed at the 6th European Breast Cancer Conference in Berlin - explains the research into Lapatinib...
Author: ecancertv
Added: 04/16/2010
EBCC6: New research shows no link between aromatase inhibitors and cardiovascular problems.
Dr Alain Monnier, Medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard.
Dr Monnier, speaking at the EBCC 6 conference in Berlin, explains ...
Author: ecancertv
Added: 04/16/2010
EBCC6: New research shows no link between aromatase inhibitors and cardiovascular problems.
Dr Alain Monnier, Medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard.
Dr Monnier, interviewed at the EBCC 6 conference in Berlin, explai...
Author: ecancertv
Added: 04/16/2010
EBCC 6: Gene expression arrays for determining breast cancer treatment.
Dimitry Nuyten, Department of Radiation Oncology and Diagnostic Oncology, Netherlands Cancer Institute, speaks at the EBCC 6 conference about the use of gene expression arrays to guide treatment of lo...
Author: ecancertv
Added: 04/16/2010
The role of funding and policies on innovation in cancer drug development
Professor Richard Sullivan, Chairman of the European Cancer Research Managers Forum, discusses the study he co-aut***d, reviewing innovation in cancer drug development. To read the paper go to http://...
Author: ecancertv
Added: 04/15/2010
UK cancer reform strategy: impact so far and next steps
Professor Richard Sullivan, from the King's Health Partners Integrated Cancer Centre at King's College London and former head of clinical programmes at Cancer Research UK, gives his round up of the We...
Author: ecancertv
Added: 04/15/2010
The experience of the Greater Manchester and Cheshire Cancer Network, and UK policy
Toni Mathie, Network Programme Director of the Greater Manchester and Cheshire Cancer Network, talks to ecancer about the impact of the UK's Cancer Reform Strategy in the North West, and future challe...
Author: ecancertv
Added: 04/15/2010
The UK's National Awareness and Early Diagnosis Initiative
National Awareness and Early Diagnosis Initiative's (NAEDI) current work and future. Interviewed at the UK's Cancer Reform Strategy Meeting, British Medical Association headquarters, London, 26th Jan ...
Author: ecancertv
Added: 04/15/2010
The future of cancer policy in the UK
Catherine Foot, from the King's Fund, discusses the challenges and future demands facing cancer care in the UK. Interviewed at the UK Cancer Reform Strategy meeting at the British Medical Association ...
Author: ecancertv
Added: 04/15/2010
ASH 2009: New target for myeloma
Dr Teru Hideshima talks about a new protein, B-Cell Lymphoma 6, as a possible new target for myeloma.
Author: ecancertv
Added: 04/15/2010
ASH 2009: Novel agents for multiple myeloma
Dr Shaji Kumar discusses the improvement in treatment of multiple myeloma with new novel agents, specifically bortezomib and lenalidomide.
Author: ecancertv
Added: 04/15/2010
ASH 2009: Tackling polyneuropathy associated with bortezomib
Dr Pieter Sonneveld discusses results of clinical trials and molecular biology work on specific side-effects of treatment, in particular polyneuropathy associated with bortezomib.
Author: ecancertv
Added: 04/15/2010
ASH 09: Studies comparing treatments for lymphoma
Dr Mathias Rummel of the University Hospital, Giessen, Germany, disucsses studies which have compared differnt lymphoma treatments.
Author: ecancertv
Added: 04/15/2010
ASH 2009: New regimens for elderly multiple myeloma patients
Dr Maria-Victoria Mateos discusses the data from a Phase III trial investigating various triplet and doublet regimens containing bortezomib in previously untreated elderly multiple myeloma patients. D...
Author: ecancertv
Added: 04/15/2010
ASH 09: Myeloid supressor cells
Prof. John Harlan talks about the latest in myeloid supressor cells and adapting immune response by targeting the tumour micro-environment.
Author: ecancertv
Added: 04/15/2010
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma
Prof. Jesus Fernando San-Miguel discusses the Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma.
Author: ecancertv
Added: 04/15/2010
ASH 2009: The International Consortium on Acute Promyelocytic Leukemia
Dr Eduardo Rego talks about The International Consortium on Acute Promyelocytic Leukemia and its work in Latin America.
Author: ecancertv
Added: 04/15/2010
ASH 09: Adult acute lymphoblastic leukaemia
Prof. Anthony Goldstone talks about adult acute lymphoblastic leukaemia and whether donor bone marrow transplantation improves outcomes.
Author: ecancertv
Added: 04/15/2010
ASH 2009: T-cell therapies
Dr Catherine Bollard discusses novel T-cell therapies and the work of her laboratory.
Author: ecancertv
Added: 04/15/2010
ASH 2009: New treatments for multiple myeloma
Prof. Antonio Palumbo discusses the two papers he presented at ASH. The first, bortezomib, melphalan, prednisone and thalidomide followed by maintenance with bortezomib and thalidomide for initial tre...
Author: ecancertv
Added: 04/15/2010
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma
Interview by Peter Goodwin in which Prof. Andrzej Jakubowiak discusses the RVDD trial, a 4-drug combination of bortezomib, lenalidomide, liposomal doxorubicin, and dexamethasone. Response rates seem i...
Author: ecancertv
Added: 04/15/2010
Multiple myeloma news from ASH 2009
ecancer round up of the multiple myeloma news to come out of the American Society of Hematology meeting in New Orleans 5-8th December 2009.
Author: ecancertv
Added: 04/15/2010
American Society of Hematology Meeting, 5-9th Dec 2009
American Society of Haematology Meeting, New Orleans, 5-9th December 2009. ecancer Managing Editor Gordon McVie gives his roundup of ASH 2009 news, excluding Multiple Myeloma, which can be found in a ...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Impact of common antidepressants on tamoxifen effectiveness
Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands
ASCO press conference: Two studies report differing results about whether the antidepressants, fluoxetine and par...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Maintenance therapy for NSCLC
Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO press conference: A phase III trial finds that adding erlotinib (Tarceva) to bevacizumab-based (Avastin) mainte...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Patient accrual in clinical trials
Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA.
ASCO press conference: New research shows that the longer it takes to develop a cancer clinical trial, the less likely it i...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Therapeutic cancer vaccine prolongs survival for follicular lymphoma
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
ASCO 2009: Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma:
An eight-yea...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Experimental targeted therapy improves progression-free survival for advanced NSCLC
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
ASCO 2009: Experimental targeted therapy with vandetanib improves progression-free survival in patients with advanced non-small cell lung can...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Oestrogen and progestin therapy increases NSCLC risk
ASCO 2009: Rowan T. Chlebowski, MD, PhD - Harbor-UCLA Medical Center - Los Angeles: Menopausal hormone therapy with oestrogen and progestin linked to increased risk of death from non-small cell lung c...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Lung cancer patients lacking MSH2 DNA repair protein fare better with chemotherapy
Pierre Fouret, MD, PhD, Institut Gustave Roussy, Université Pierre et Marie Curie, Paris, France: Speaking at ASCO 2009:
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Surgery unnecessary for majority of patients with advanced colorectal cancer
Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA - speaking at ASCO 2009 press conference:
New research shows that patients who are newly diagnosed with metastatic, surgi...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Low rates of screening among childhood cancer survivors
Dr. Paul Nathan - Hospital for Sick Children, Toronto, Canada - speaking at ASCO 2009 press conference:
Too few survivors of childhood cancer are getting recommended screenings for cancers of the ...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma
Patrick Hwu, MD, Chair of the Department of Melanoma Medical Oncology M. D. Anderson Cancer Center:
Therapeutic vaccine improves response rate and extends progression-free survival in patients wit...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Bevacizumab and standard adjuvant chemotherapy
ASCO 2009: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer.
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny Gener...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Childhood cancer survivors at risk of post-traumatic stress disorder
Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA - speaking at ASCO 2009 press conference:
Report shows that the incidence of post-traumatic stress d...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: PARP inhibitor BSI-201 plus chemotherapy: new option for triple-negative breast cancer
Joyce OShaughnessy, MD, Baylor-Charles A. Sammons Cancer Center, Dallas, Texas, speaking at ASCO 2009:
PARP inhibitor BSI-201 plus chemotherapy may offer new treatment option for triple-negative b...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Trial compares common adjuvant treatments for pancreatic cancer
Dr. John Neoptolemos - University of Liverpool, Liverpool, UK - speaking at the ASCO 2009 press conference:
A phase III trial comparing the adjuvant treatments most commonly used for pancreatic ca...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Lung cancer screening by low-dose computed tomography results in high rate of false positives
Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, USA - speaking at ASCO press conference:
A new study finds that lung cancer screening using low-dose computed tomograp...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Treatment based on rising CA125 blood levels does not improve survival for ovarian cancer
Gordon Rustin, MD, Mount Vernon Cancer Center, Hertfordshire, United Kingdom, speaking at ASCO 2009:
Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian can...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Sentinel node biopsy is an effective less invasive option for early-stage cervical cancer patients
Fabrice Lecuru, MD, PhD, George Pompidou European Hospital, Paris, France, speaking at ASCO 2009:
Sentinel node biopsy is an effective, less invasive option for early-stage cervical cancer patients...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Standard treatment plus trastuzumab for HER2+ gastric cancer
Eric Van Cutsem, MD, PhD, University Hospital Gasthuisberg, Leuven, Belgium, speaking at ASCO 2009:
Adding trastuzumab to standard treatment improves survival in patients with HER2-positive gastric...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Prophylactic creams and antibiotics reduce severe drug-related skin rash
Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ASCO press conference: Giving colon cancer patients a combination of moisturisers, sunscreen, topical steroids and ...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Partial Breast Irradiation
Dr. Davide Mauri discusses trials that have shown the partial breast irradiation does not jeopardise survival or the risk of metastasis.
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Pemetrexed extends survival as maintenance therapy
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA, speaking at the ASCO press conference:
A phase III study reports that maintenance therapy with pemetrexed (Alimta) ...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Oxaliplatin does not improve outcomes for rectal cancer
Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy - speaking at the ASCO press conference:
Adding oxaliplatin (Eloxatin) to standard treatment in patients with locally advanced rectal cancer does ...
Author: ecancertv
Added: 04/15/2010
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Andrew Tutt, MB, ChB, PhD, Kings College London, United Kingdom, speaking at ASCO 2009:
PARP inhibitor olaparib induces tumour response as single agent in BRCA-deficient breast cancer: A small, Pha...
Author: ecancertv
Added: 04/15/2010
Combing radiotherapy, gemcitabine and cisplatin as treatment for cervical cancer.
Dr Alfonso Dueñas-González discusses the combination of gemcitabine and cisplatin chemotherapy with radiotherapy as a way of treating cervical cancer.
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals.
Results of Phase II study comparing Orazol (zoledronic acid in oral form) to Zometa (zoledronic acid IV) injections in trea...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Bortezomib based therapies for myeloma
Dr Paul Richardson, Hematologic Oncology Dept, Dana-Farber Cancer Institute, speaking at ASCO 2009 about Bortezomib based therapies in relapsed and refractory myeloma. Tanespimycin with bortezomib (so...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Cancer prevention strategies
Professor Peter Boyle, International Prevention Research Institute.
Prof. Boyle discusses the issue of world cancer disparities such as risk factors and treatment and how the International Preventi...
Author: ecancertv
Added: 04/15/2010
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston, Centre for Cancer Research & Cell Biology, Queen's University Belfast, discusses his work targeting the BCL2 protein family and other inhibitors of cell apoptosis in order t...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: PSA/Prostate screening
Dr. Otis W. Brawley - Chief Medical Officer, ACS.
Prostate cancer screening studies and ASCO 2009
Author: ecancertv
Added: 04/15/2010
ASCO 2009: Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Study to evaluate the frequency of complete pathologic response after neo-adjuvant treatment with cisplatin chemotherapy in women ...
Author: ecancertv
Added: 04/15/2010
ASCO 2009: PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK
A study reports that women with BRCA deficient advanced breast cancer experienced tumour shrinkage after receiving...
Author: ecancertv
Added: 04/15/2010
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues
Alexander M. M. Eggermont (NL), President of ECCO, Congress Chair and Oncopolicy Track; Co-Chair Kathy Oliver (UK), Co-Director of the International Brain Tumour Alliance; Maciej Krzakowksi (PL), The ...
Author: ecancertv
Added: 04/15/2010
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Discover just some of the many reasons for attending the ECCO 15-ESMO 34 conference in Berlin.
A roundtable discussion with: Fatima Cardoso (BE), Co-Chair, Breast Cancer – Advanced Disease Track; Ra...
Author: ecancertv
Added: 04/15/2010
Pleural Mesothelioma | Dr. Julie Brahmer
http://www.curemeso.org... --- Video of Dr. Brahmer's presentation at the International Symposium on Malignant Mesothelioma 2009.
Author: mesothelioma_applied_research_foundation
Added: 04/12/2010
Peritoneal Mesothelioma | John Chabot, MD
http://www.curemeso.org... --- Video presentation from the International Symposium on Malignant Mesothelioma 2009.
Author: mesothelioma_applied_research_foundation
Added: 04/12/2010
Pleural Mesothelioma | Mesothelioma Applied Research Foundation
http://www.curemeso.org... ---- Video presentation of Dr. Flores at the International Symposium on Malignant Mesothelioma 2009.
Author: mesothelioma_applied_research_foundation
Added: 04/12/2010
Martin Kemp opens HCA Gamma Knife Centre
The actor and Spandau Ballet singer Martin Kemp has opened the revolutionary Gamma Knife Centre to treat brain tumours. The centre is a £3 million joint venture between HCA, the leading London private...
Author: hcacancercare
Added: 04/09/2010
The 100th CyberKnife Patient
A man from Greater London has become the 100th person to be treated at the UK's first CyberKnife Centre at the renowned Harley Street Clinic in London.
The man, who has been suffering from prostate...
Author: hcacancercare
Added: 04/09/2010
Neurosurgery at The Wellington Hospital
Lewis Thorne is a consultant neurosurgeon looking after patients at both The Wellington Hospital in St Johns Wood, London and the nearby Royal Free hospital in Hampstead. His specialist area of intere...
Author: hcacancercare
Added: 04/09/2010
Prof Martin Birchall - Advances in Technology
Prof Martin Birchall reviews the advances in technologies and treatments available for patients with voice and throat disorders, including the transnasal esophagoscope, intensity modulated therapy for...
Author: hcacancercare
Added: 04/08/2010
Prof Martin Birchall - Cancer of the Vocal Cords
Prof Martin Birchall discusses the case of a patient suffering from hoarseness and highlights the importance of early GP referrals in cases such as this. After performing an endoscopy, Prof Birchall i...
Author: hcacancercare
Added: 04/08/2010
Radiation Treatment: Safe and Effective for Patients
Radiation treatment plays a critical role in managing cancer, and advances in radiation oncology have been significant and steady since its first clinical application more that 65 years ago. Those of ...
Author: mdanderson
Added: 04/07/2010
Dr. Robert Uzzo M.D., Fox Chase Cancer Center, - management of small cell renal masses localized renal cell carcinnoma case presentation
Eighth International Kidney Cancer Symposium - Robert Uzzo, M.D., FACS. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is f...
Author: kidneycancer
Added: 04/05/2010
Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses small renal masses: partial nephrectomy
Eighth International Kidney Cancer Symposium - Paul Russo, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely av...
Author: kidneycancer
Added: 04/05/2010
Dr. Jeffrey Cadeddu M.D., UT Southwestern Medical Center - Small renal masses: thermal ablation
Eighth International Kidney Cancer Symposium - Jeffrey Caddedu, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is free...
Author: kidneycancer
Added: 04/05/2010
Dr. Michael Jewett, M.D., FACS Professor of Surgery, Division of Urology University of Toronto, - Small renal masses: active surveillance
Eighth International Kidney Cancer Symposium - Michael Jewett, M.D., FRCSC, FACS. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and v...
Author: kidneycancer
Added: 04/05/2010
Dr. Astrid Van der Veldt, M.D., VU University Medical Center, Amsterdam, Netherlands., talks about Choi criteria
Eighth International Kidney Cancer Symposium - Astrid Van der Veldt, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is...
Author: kidneycancer
Added: 04/05/2010
Dr. Allan Pantuck M.D., Ronald Reagan UCLA Medical Center, Management of Locally Advanced RCC Case Presentation
Eighth International Kidney Cancer Symposium - Allan Pantuck, M.D., F.A.C.S. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos...
Author: kidneycancer
Added: 04/05/2010
Dr. Michael Blute, M.D., UMass Memorial Health Care and UMass Medical School, Lymph Node Dissection
Eighth International Kidney Cancer Symposium - Michael Blute, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely...
Author: kidneycancer
Added: 04/05/2010
Dr. Eric Jonasch, M.D of MD Anderson talks about Neoadjuvant Therapy in locally advance disease
Eighth International Kidney Cancer Symposium - Eric Jonasch, M.D. For more in this series: www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is freely ...
Author: kidneycancer
Added: 04/05/2010
Milano 27-02-10 3° Convegno Nazionale AIG: Aspetti etici della sperimentazione
Dott. Roberto Satolli, Presidente del Comitato Etico Indipendente della Fondazione IRCCS Istituto Nazionale dei Tumori, MIlano
Author: gistonline
Added: 03/31/2010
Milano 27-02-10 3° Convegno Nazionale AIG: La corretta diagnosi
Dott. Angelo Paolo Dei Tos, Direttore del Dipartimento di Oncologia
Azienda ULSS 9, Treviso
Author: gistonline
Added: 03/31/2010
Milano 27-02-10 3° Convegno Nazionale AIG: La chirurgia del residuo in risposta a Imatinib
Dott. Alessandro Gronchi, UO Sarcoma e Melanoma, Dipartimento di Chirurgia Fondazione IRCCS Istituto Nazionale Tumori Milano
Author: gistonline
Added: 03/24/2010
Milano 27-02-10 3° Convegno Nazionale AIG: Farmaci approvati, off-label e sperimentazioni
Dott. Paolo G. Casali, Responsabile SS Trattamento Medico Sarcomi Adulto
Fondazione IRCCS Istituto Nazionale dei Tumori, MIlano
Author: gistonline
Added: 03/24/2010
Axel Grothey - Colorectal and Non-Colorectal Gastrointestinal Cancers Event
Colorectal and Non-Colorectal Gastrointestinal Cancers:
Comprehensive Review and Update
Saturday, April 10, 2010
Program Director - Axel Grothey, MD, Professor of Oncology and Consultant, Mayo Clin...
Author: knaidu
Added: 03/23/2010
Deborah Armstrong, MD, Johns Hopkins Kimmel Cancer Center, discusses Early studies of enzastaurin and bevacizumab.
Full interview...
http://elc.imedex.com/?proj...
* Early studies of enzastaurin and bevacizumab
* Single nucleotitde polymorphisms (SNPs)
* BRCA1 and association with clinical...
Author: imedex
Added: 03/22/2010
Thomas J. Herzog, MD, Columbia University College of Physicians and Surgeons talks about liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy.
Full interview...
http://elc.imedex.com/?proj...
* Liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy
* Erlotinib in squamous cell carcinoma...
Author: imedex
Added: 03/22/2010
Carolyn Runowicz, MD, of University of Connecticut Health Center reveals the impact of quadrivalent vaccine in women with cervical cancer
Full interview...
http://elc.imedex.com/?proj...
* Cervical and endometrial cancer screening and prevention
* Impact of quadrivalent vaccine in women with cervical cancer
Author: imedex
Added: 03/22/2010
James T. Thigpen, MD, University of Mississippi Medical Center discusses CA125 use as a clinical indicator.
Full interview...
http://elc.imedex.com/?proj...
* Platinum sensitive, recurrent ovarian cancer studies
* Targeted agents
* CA125 use as a clinical indicator
Author: imedex
Added: 03/22/2010
The Division of Thoracic Surgery
The Division of Thoracic Surgery at Greater Baltimore Medical Center offers expertise in the general thoracic surgery field and includes cutting-edge multimodality cancer treatment and minimally invas...
Author: gbmc
Added: 03/22/2010
Bradley J. Monk, MD, University of California Irvine talks about role of bevacizumab – cost effectiveness analysis
Full interview...
http://elc.imedex.com/?proj...
* Optimal treatment of early-stage ovarian cancer
* Role of bevacizumab – cost effectiveness analysis
* Gynecologic Oncology ...
Author: imedex
Added: 03/22/2010
Robert L. Coleman, MD of the M. D. Anderson Cancer Center talks about intraperitoneal versus intravenous chemotherapy in ovarian cancer
Full interview...
http://elc.imedex.com/?proj...
* Intraperitoneal versus intravenous chemotherapy in ovarian cancer
* BRCA mutations in ovarian cancers
* American Congress o...
Author: imedex
Added: 03/22/2010
New ACS Guidelines on Screening for Prostate Cancer
Recently, the American Cancer Society updated its recommendations regarding screening for prostate cancer. They differ from recommendations of other organizations. This video discusses them and wha...
Author: prostatevideos
Added: 03/16/2010
Living with Fear: A Prostate Cancer Special
Follow Mike Robitaille, Buffalo Sabres hockey analyst, through his experience with a routine prostate cancer screening exam - or what he thought would be routine. This 30-minute TV special will air on...
Author: roswellpark
Added: 03/15/2010
Understanding Potential Side Effects after Treatment for Localized Prostate Cancer
Men weighing their options for localized prostate cancer need to know the odds that each side effect might occur. Ideally this information has been gathered from validated surveys completed by patient...
Author: prostatevideos
Added: 03/14/2010
Screening for Prostate Cancer- Should You or Shouldn't You
A discussion of the risks and benefits of screening for prostate cancer based on available scientific studies
Author: prostatevideos
Added: 03/14/2010
New Guidelines Regarding Active Surveillance of Low Risk Prostate Cancer
Active Surveillance is being recognized as an increasingly important option for men with a PSA less than 10 ng/ml, a Gleason score of 6 and a normal prostate exam. The question for patients is how str...
Author: prostatevideos
Added: 03/14/2010
Long Term Implications of PSA Testing
The PSA test has been available for approximately 20 years. The question for many is how beneficial has it been. A recent study assessed the overall impact in terms of additional cancers diagnosed and...
Author: prostatevideos
Added: 03/14/2010
Is Proton Radiation Safer or More Effective than Other Radiation for Localized Prostate Cancer.
Proton Beam Therapy has been used to treat many men with localized prostate cancer. In theory, it may be safer or better than photon radiation but the question is what is really known about it. A rece...
Author: prostatevideos
Added: 03/14/2010
Is Minimally Invasive Radical Prostatectomy Safer and_or More effective than Open Prostatectomy.
Considerable publicity surrounds the possible benefits of minimally invasive radical prostatectomy for prostate cancer. Unfortunately, no randomized studies have ever supported this claim. This video ...
Author: prostatevideos
Added: 03/14/2010
Is External Radiation Using the Calypso Tracking System Better than IMRT for prostate cancer.
One of the newer modifications for administering external beam radiation is the use of the Calypso Tracking system which constantly adjusts the beam to minimize radiation beyond the prostate gland. Ad...
Author: prostatevideos
Added: 03/14/2010
Indications and Extent of Pelvic Node Dissection for Men undergoing Radical Prostatectomy_1
Historically, pelvic nodes were removed in men undergoing radical prostatectomy to determine if the disease was more extensive. Most doctors performed a 'limited' dissection to minimize side effects. ...
Author: prostatevideos
Added: 03/14/2010
Hormone Therapy + XRT for Locally Advanced Prostate Cancer- What is the Best Duration.
Several studies have found that hormone therapy improves the survival of men with locally advanced prostate cancer who are treated with external radiation. Considerable debate has remained over what d...
Author: prostatevideos
Added: 03/14/2010
Watch this video in a new window Does Robotic Prostatectomy Cause More Impotence and Incontinence than Open Prostatectomy?
A recent study was published in the Journal of the American Medical Association in October, 2009 that compared results for open vs. minimally invasive radical prostatectomy. The authors found that min...
Author: prostatevideos
Added: 03/14/2010
Does Hormone Therapy Cause Heart Attacks in Men with Prostate Cancer?
Hormone therapy or reducing testosterone has clear benefits for patients with prostate cancer and significant side effects. One that has been more recently identified is the increased risk of cardiova...
Author: prostatevideos
Added: 03/14/2010
NCCN Prostate Cancer Guidelines
Mike Robitaille, Buffalo Sabres Hockey Analyst, urges men to learn about the updates made by the National Comprehensive Cancer Network (NCCN) to the prostate cancer treatment guidelines. Active survei...
Author: roswellpark
Added: 03/13/2010
Let's Talk about Prostate Cancer: Integrative Oncology (Gary Deng, MD PhD)
Many prostate cancer patients rely on complementary and/or alternative treatments. In this video, Dr. Gary Deng of the Integrative Oncology Department at Memorial Sloan Kettering Cancer Center shares ...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer- Video Education Gerald Chodak MD
Dr. Chodak, a surgeon, is the founder of ProstateVideos.com, a long-time advocate for the appropriate application of techniques such as active surveillance, and the urologist who brought some patients...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer: Public Education and Collaboration (Michael Scott)
E. Michael (Mike) D. Scott is a long-time prostate cancer activist and educator, co-founder of Prostate Cancer International and the Prostate Cancer Community Awareness Councils.
http://pcainterna......
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer with Charles "Snuffy" Myers, MD
Charles Snuffy Myers, MD is a fee for counsel medical oncologist, a prostate cancer patient, and founder of the American Institute for Diseases of the Prostate. He practices in Earlysville, VA, where ...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer with Mark Scholz, MD
Mark Scholz, MD is a community-based medical oncologist practicing in Los Angeles, CA. He specializes exclusively in the treatment of men with prostate cancer. He is also a co-founder, an member of th...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer with Lisa Chaiken MD
Dr. Lisa Chaiken is a community-based radiation oncologist who practices in Santa Monica, California. She talks about some of the recent developments in the roles of radiation therapy in the treatment...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer with John Mulhall MD
Dr. John Mulhall of the Memorial Sloan-Kettering Cancer Institute talks about the relationship between prostate cancer treatment and erectile dysfunction and current mechanisms to manage the potential...
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer: Building Bridges (Arnon Krongrad, MD)
Dr. Krongrad is the Chairman of the Prostate Cancer Mission, a co-founder of Prostate Cancer International, and a highly regarded specialist in minimally invasive prostate surgery.
Author: pci
Added: 03/13/2010
Let's Talk about Prostate Cancer with Dr. David Heber, MD
David Heber, MD is the Director of the Center for Human Nutrition at UCLA. One of his special interests is the relationships between nutrition and cancer, and he has over 20 years of experience in thi...
Author: pci
Added: 03/13/2010
Donald Trump's pep talk to our Dr. Donald Trump
Donald Trump shared these words of encouragement for Dr. Donald Trump, CEO and President of Roswell Park, before he shaved both head and mustache at the kick off of the national Goin' Bald For Buck......
Author: roswellpark
Added: 03/13/2010
Let's Talk about Prostate Cancer: A Urologist With Prostate Cancer (Paul Schellhammer, MD)
Paul Schellhammer, MD, former President of the American Urological Association, is a long-time leading authority on the management of prostate cancer. Dr. Schellhammer talks about his own progressive ...
Author: pci
Added: 03/12/2010
Let's Talk about Prostate Cancer with Arthur Lurvey, MD
Dr. Arthur Lurvey is a member of the board of directors of the Prostate Cancer Research Institute and the California Prostate Cancer Coalition. He is also a medical director with a major California......
Author: pci
Added: 03/12/2010
Milano 27-02-10 3° Convegno Nazionale AIG: Apertura Convegno
Anna Costato Presidente AIG, Dr Gerolamo Corno direttore generale IRCCS Istituto Nazionale Tumori Milano, Dr Marco Pierotti direttore scientifico IRCCS Istituto Nazionale Tumori Milano
Author: gistonline
Added: 03/11/2010
Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer
Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer at ASCO GU Conference from San Francisco. Direct Link...http://elc.imedex.com/?proj......
Author: imedex
Added: 03/08/2010
Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic on Who are the candidates for prevention therapy?
Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic on "Who are the candidates for prevention therapy?" Direct Link...http://elc.imedex.com/?proj...
Author: imedex
Added: 03/08/2010
Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic are asked Screening-what are the guidelines and what do you recommend?
Dr. Robert Dreicer, MD, FACP and Dr. Eric Klein, MD of the Cleveland Clinic are asked "Screening-what are the guidelines and what do you recommend?" Direct Link...http://elc.imedex.com/?pro......
Author: imedex
Added: 03/08/2010
Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses Renal Cell Cancer-Surgical management & high risk disease.
Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, New York discusses Renal Cell Cancer-Surgical management & high risk disease at the ASCO GU Conference 2010 Direct Link... http://elc.ime......
Author: imedex
Added: 03/08/2010
Dr. Gary Hudes, MD Fox Chase Cancer Center, discusses Management of advanced RCC
Dr. Gary Hudes, MD Fox Chase Cancer Center, in Philadelphia discusses Management of advanced Renal Cell Cancer at the 2010 ASCO GU Conference in San Francisco. Direct link...http://www.imedex.com...
Author: imedex
Added: 03/08/2010
Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, Discusses Bladder Cancer and Rare GU Tumors
Dr. Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, in New York Discusses Bladder Cancer and Rare GU Tumors at the ASCO Genitourinary Conference in San Francisco.
Direct link...http://el......
Author: imedex
Added: 03/08/2010
ONS Foundation at Congress 2010
Margaret Hansen Frogge, President of the ONS Foundation, talks about some of the events and opportunities that the Foundation will provide at the 35th annual ONS Congress in San Diego, CA, May 13-16, ...
Author: oncologynurses
Added: 03/02/2010
San Diego ONS Chapter is Wild About Congress
The San Diego chapter of ONS shares some reasons why they're wild about hosting the 35th annual ONS Congress in May 2010.
Author: oncologynurses
Added: 03/02/2010
ONS on NMR
An eight-minute segment produced by National Medical Report about the Oncology Nursing Society.
Author: oncologynurses
Added: 03/01/2010
Brenda Nevidjon on Health Care
ONS President Brenda Nevidjon urges nurses to get involved in the current health care debate.
Author: oncologynurses
Added: 03/01/2010
Heidi Lucas
Naturopathic physician Heidi Lucas explains naturopathic oncology, which she presented to the 2009 APN Conference in Tampa, FL on Friday, November 13, 2009.
Author: oncologynurses
Added: 03/01/2010
Patrick Coyne
Patrick Coyne from the VCU M***ey Cancer Center talking about his session on palliative care at the 2009 APN Conference in Tampa, FL.
Author: oncologynurses
Added: 03/01/2010
Cyndi Cramer
Cyndi Cramer talking about her subject for the ONS Trish Greene Quality of Life Lecture at the 2009 Institutes of Learning (IOL) in Tampa, FL
Author: oncologynurses
Added: 02/24/2010
Congress 2010 - Kristen Baileys
Kristen Baileys, president of the Greater Pittsburgh Chapter of ONS, talks about the upcoming 35th annual ONS Congress in San Diego, CA.
Author: oncologynurses
Added: 02/24/2010
Multiple Myeloma and Oncology Nurses
Kena Miller, MSN, FNP describes the critical role of nurses in the treatment and management of multiple myeloma. ManagingMyeloma.com has increased our nurse focus in 2010 with more nurse-specific cont...
Author: managingmyeloma
Added: 02/22/2010
Dr Richardson on Managing Myeloma
A video teaser for ManagingMyeloma.com, by national thought leader, Dr. Paul Richardson. Go to http://www.managingmyeloma.... to view theme month videos and listen to expert analysis of the practice ...
Author: managingmyeloma
Added: 02/22/2010
Pat Neal, RN with Ginger Sawyer and Carol Gangstead: Side effects of Tyrosine Kinase Inhibitors
.
Author: gistsupport
Added: 02/16/2010
Haesun Choi, MD: Radiologic imaging: Responding or Not Responding -- Lessons from the GIST Model
Lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center
Author: gistsupport
Added: 02/15/2010
Ask the Expert Session featuring Haesun Choi, MD and Pat Neal, RN
.
Author: gistsupport
Added: 02/14/2010
CytoCare - The better way to compound hazardous IVs
CytoCare automates the compounding of hazardous IVs used for chemotherapy, monoclonal antibody therapy, and genetic therapy. The result:
- Better patient care – Automated compounding improves accu...
Author: mckesson
Added: 02/11/2010
Annals of Oncology: An introduction
Editor-in-Chief Prof. Jan B. Vermorken outlines his vision for the journal Annals of Oncology, along with some recent and forthcoming developments. Dr. Nagahiro Saijo, President Emeritus of the Japane...
Author: annals_oncology
Added: 02/11/2010
Georgia Cancer Specialists's Totes 2 Tots Suitcase Drive for Foster Kids
Every year, Georgia Cancer Specialists hosts the Totes 2 Tots suitcase drive for Georgia's foster children. This year, more than 4,200 bags were collected. In the eight years since the program's incep...
Author: georgia_cancer_specialists
Added: 02/10/2010
7 Things You Should Know About Lung Cancer
Georgia Cancer Specialists physician Dr. Rodolfo Bordoni shares seven things you should know about lung cancer.
Author: georgia_cancer_specialists
Added: 02/10/2010
7 Things You Can Do if a Loved One is Diagnosed with Cancer
Georgia Cancer Specialists nurse Kimberly Auriemma shares seven things you can do if one of your loved ones is diagnosed with cancer.
Author: georgia_cancer_specialists
Added: 02/10/2010
7 Things You Should Know About Breast Cancer
Dr. Bruce Feinberg, president and CEO of Georgia Cancer Specialists, shares seven things you should know about breast cancer.
Author: georgia_cancer_specialists
Added: 02/10/2010
7 Things You Should Know About Colon Cancer
Dr. Bruce Feinberg, president and CEO of Georgia Cancer Specialists, shares seven very important things you should know about colon cancer.
Author: georgia_cancer_specialists
Added: 02/10/2010
Recently Diagnosed with Cancer? 7 Reasons You Should Have Hope
Georgia Cancer Specialists physician Dr. Jayanthi Srinivasiah (Dr. Jay) shares seven reasons you should have hope if you were recently diagnosed with cancer.
Author: georgia_cancer_specialists
Added: 02/10/2010
Georgia Cancer Specialists is Your Breast Cancer Answer
Learn why Georgia Cancer Specialists is your breast cancer answer.
Author: georgia_cancer_specialists
Added: 02/10/2010
Ask the Experts session featuring Suzanne George, MD; Laura Nolden, MS; and Tony Conley, MD
Panel Discussion from the 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer enter
Author: gistsupport
Added: 02/05/2010
Suzanne George, MD: The Role of Drug Plasma Level Testing in Metastatic GIST
lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center
Author: gistsupport
Added: 02/05/2010
Peter Pisters, MD FACS: Adjuvant therapy and surgical management of GIST
lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center
Author: gistsupport
Added: 02/04/2010
Jon Trent, MD: New Therapies for GIST
lecture from 2009 GIST Information and Therapy Summit organized by GIST Support International and MD Anderson Cancer Center
Author: gistsupport
Added: 02/04/2010
Wells Messersmith, MD, ASCO GI 2010
Dr Axel Grothey interviews Dr. Wells Messersmith from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on...
Author: imedex
Added: 02/01/2010
Cathy Eng, MD, FACP, ASCO GI 2010
Dr Axel Grothey interviews Dr. Cathy Eng from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on clinica...
Author: imedex
Added: 02/01/2010
Andrew X. Zhu, MD, PhD - ASCO GI 2010
Dr Axel Grothey interviews Dr. Andrew X. Zhu from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on cli...
Author: imedex
Added: 02/01/2010
Fighting Drug Resistance in CML
Dr. Richard Larson talks about patients concerns over drug resistance and the role of old drugs.
Author: patientpower
Added: 12/16/2009
Research on the Horizon for Hematologic Malignancies
Dr. Alan Gewirtz discusses research and new strategies for harnessing the immune system.
Author: patientpower
Added: 12/16/2009
An Expert's Perspective on the Latest CLL News
Dr. Michael Keating discusses the extended data and therapeutic challenges surrounding CLL.
Author: patientpower
Added: 12/16/2009
New Drug Combinations in CLL and Promising Research
Dr. Thomas Kipps discusses new agents and drug combinations being used to treat CLL.
Author: patientpower
Added: 12/16/2009
Bendamustine + Rituxan vs. CHOP + R for Indolent Lynphomas
Dr. Mathias Rummel talks about a new study showing how one old drug combined with a new drug is showing promise over the standard approach.
Author: patientpower
Added: 12/16/2009
Multiple Myeloma Maintenance Therapy
Dr. Maria-Victoria Mateos talks about a new study from Spain revealing how lower doses of newer drugs can be used in the long-term to fight cancer with much lower side effects.
Author: patientpower
Added: 12/15/2009
Vaccine Therapy for Blood Related Cancers
Dr. Carl June discusses promising research surrounding vaccine therapy for patients with blood related cancers.
Author: patientpower
Added: 12/15/2009
On the Horizon: Chemo Drugs No Longer Needed?
Dr. Ronald Levy talks about the possibility of no longer needing chemo and the role of antibodies.
Author: patientpower
Added: 12/15/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 W. Frasier Symmans, MD
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 W. Frasier Symmans, MD
Author: imedex
Added: 12/15/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Stephen F. Sener, MD
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Stephen F. Sener, MD
Author: imedex
Added: 12/15/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Hope S. Rugo, MD
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Hope S. Rugo, MD
Author: imedex
Added: 12/15/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Ruth O'Regan, MD
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Saturday December 12, 2009 Ruth O'Regan, MD
Author: imedex
Added: 12/15/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 William Gradishar, MD, FACP
2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Friday December 11, 2009 William Gradishar, MD, FACP
Author: imedex
Added: 12/14/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Thursday December 10, 2009 Mary Cianfrocca, DO
2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Thursday December 10, 2009 Mary Cianfrocca, DO
Author: imedex
Added: 12/14/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Harold Burstein, MD, PhD
2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Friday December 11, 2009 Harold Burstein, MD, PhD
Author: imedex
Added: 12/14/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Thursday December 10, 2009 George T. Budd, MD
2009 San Antonio Breast Cancer Symposium (SABCS) Best of the Day - Thursday December 10, 2009 George T. Budd, MD
Author: imedex
Added: 12/14/2009
San Antonio Breast Cancer Symposium (SABCS) 2009 Best of the Day - Friday December 11, 2009 Kimberly Blackwell, MD
Best of the Day from the 2009 San Antonio Breast Cancer Symposium (SABCS) - Friday December 11, 2009 Kimberly Blackwell, MD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gail J. Roboz, MD
ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gail J. Roboz, MD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Monday, December 7, 2009 Vincent Rajkumar, MD
ASH 2009 Best of the Day - Monday, December 7, 2009 Vincent Rajkumar, MD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Tuesday, December 8, 2009 Owen A. O'Connor, MD, PhD
ASH 2009 Best of the Day - Tuesday, December 8, 2009 Owen A. O'Connor, MD, PhD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Monday, December 7, 2009 Susan O'Brien, MD
ASH 2009 Best of the Day - Monday, December 7, 2009 Susan O'Brien, MD
Author: imedex
Added: 12/14/2009
Ruben A. Mesa, MD, ASH 2009 Best of the Day - Monday, December 7, 2009
ASH 2009 Best of the Day - Monday, December 7, 2009 Ruben A. Mesa, MD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Myron Czuczman, MD, Sunday, December 6, 2009
ASH 2009 Best of the Day - Myron Czuczman, MD, Sunday, December 6, 2009
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Monday, December 7, 2009 Jorge Cortes, MD
ASH 2009 Best of the Day - Monday, December 7, 2009 Jorge Cortes, MD
Author: imedex
Added: 12/14/2009
ASH 2009 Best of the Day - Monday, December 7, 2009 Kenneth Anderson, MD, MA
ASH 2009 Best of the Day - Monday, December 7, 2009 Kenneth Anderson, MD, MA
Author: imedex
Added: 12/14/2009
Gary Schiller, MD, ASH 2009 Best of the Day - Tuesday, December 8, 2009
ASH 2009 Best of the Day - Tuesday, December 8, 2009 Gary Schiller, MD
Author: imedex
Added: 12/14/2009
Jeffrey N. Weitzel, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Stephen F. Sener, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Allen Lipton, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Marjorie Green, MD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Rowan T. Chlebowski, MD, PhD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Harold Burstein, MD, PhD, Best of the Day from the 2009 American Society of Clinical Oncology Breast Cancer Symposium
This video activity is filmed onsite during the 2009 Breast Cancer Symposium and is composed of 6 interviews with thought leaders involved in various aspects of breast cancer management. Drs Christy R...
Author: imedex
Added: 11/29/2009
Stephen Schuster, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
Martin Hutchings, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
Jean-Luc Harousseau, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
Rafael Fonseca, MD , Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
Volker Diehl, MD , Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
Kanti Rai, MD, Best of the Day from Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews expe...
Author: imedex
Added: 11/29/2009
ASH 2008 Interview Dr. Ferrajoli
Radon therapy in Switzerland
Author: imedex
Added: 05/13/2009
Oreilly ASCO Gastro Intestinal Interview
Interview with Dr. Oreilly
Author: imedex
Added: 05/13/2009
Help: How to Play a Video on OncologyTube and Features
In this tutorial we'll show you how to play a video on OncologyTube and some of the features of the player such as scrubbing and full screen mode.
Author: help
Added: 04/05/2008
Help: How to Post a Comment on a Video
In this tutorial we'll show you how to post a comment on a video.
Author: help
Added: 04/05/2008
Help: Send a Link to a Friend
In this tutorial we'll be covering how to use the "Video URL" link to send someone a direct link to a video on OncologyTube via email.
Author: help
Added: 04/05/2008
Help: Embedding OncologyTube Videos on an External Site
In this tutorial we will show you how to use the embed tag to have the video play on an external site.
Author: help
Added: 04/05/2008
Help: Adding Power Point Slides and Transcripts
In this tutorial we will go over how to attach downloadable Power Point slides and transcripts to a video hosted on OncologyTube.
Author: help
Added: 04/05/2008
Help: How to Subscribe to a Channel
You may find some particular content providers on OncologyTube worth getting updates about. In this tutorial we show you how to subscribe and unsubscribe to someone's channel and the general benefits.
Author: help
Added: 04/05/2008
Help: How to Customize the Look of My Channel
In this tutorial we go over how to change the colors and rearrange videos on your channel. There are many other modifications that can be made to a channel on OncologyTube to personalize it for you, ...
Author: help
Added: 04/05/2008
Help: How to Delete a Video
In this quick tutorial we'll show you how to permanently delete a video you have uploaded to OncologyTube.
Author: help
Added: 04/05/2008
Help: How to Make Changes to My Account
In this tutorial we describe how to make corrections or alterations to your account including changing email address, p***word, uploading a picture, adding your website, and other data to your account...
Author: help
Added: 04/05/2008
Help: How to Set Up an Account (It's Free!)
In this tutorial we will go through how easy and quick it is to set up a free account with OncologyTube. Once you set up an account you can upload your own videos, comment on other videos and a host o...
Author: help
Added: 04/05/2008
Help: Uploading Videos
Learn how to upload videos on OncologyTube.com. This tutorial goes over the 2 step process for uploading videos to OncologyTube.com. Formats we accept are FLV, Mpeg, QuickTime, and AVI.
Author: help
Added: 04/05/2008
Help: How do I Search or Browse for Videos?
In this tutorial we go over the differences between searching and browsing for videos on OncologyTube and the strengths or both.
Author: help
Added: 04/05/2008
No comments:
Post a Comment